Moderna on Wednesday said it will soon seek emergency use authorization for its two-dose COVID-19 vaccine in children under six years old, after preliminary data showed kids in that age group had a similar immune response to adolescents and young adults when given a smaller dose of the vaccine.
READ MORE: http://hill.cm/O1CPH2w